Key result
Depression worsens quality of life and increases mortality risk in patients with heart failure, with its pathophysiology negatively impacting the pathogenesis of the disease.
This review highlights the negative impact of depression on the pathogenesis, quality of life, and mortality risk in patients with heart failure.
Supports integrating depression assessment into heart failure care; leaves open whether treatment modifies pathogenesis or survival.
Chronic heart failure is a widespread condition and its prevalence in the UK continues to grow. Living with chronic heart failure can severely impair longevity and quality of life. Despite the known severe impact this chronic disease has on patients’ lives, little research has explored the prevalence of depression among the UK heart failure population. Recent evidence suggests that depression may not only further worsen the already diminished quality of life for heart failure patients, but it may also significantly increase the mortality risk of the patient living with heart failure. This article reviews current evidence and guidelines to consider the prevalence of depression among UK heart failure patients and illustrates how the pathophysiology of depression negatively impacts on the pathogenesis of heart failure.
No takes yet. Share an insight, caveat, or question.
Doireann McGowan (2013) conducted a review in Chronic heart failure and depression. Depression was evaluated. Depression worsens quality of life and increases mortality risk in patients with heart failure, with its pathophysiology negatively impacting the pathogenesis of the disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: